Protein Tyrosine Phosphatase 1B (PTP1B) in obesity and type 2 diabetes

Research output: Contribution to journalArticle

Abstract

Increased incidence in obesity is reaching epidemic proportions and is
placing a major burden on the healthcare systems in developed countries.
Obesity is a major risk factor for the development of type 2 diabetes, metabolic
syndrome, cardiovascular disease and cancer. Thus, the search for
molecules that regulate the development of obesity and its associated pathologies
is ongoing. Protein tyrosine phosphatase 1B (PTP1B) has been
found to be a major regulator of body fat stores, energy balance, and insulin
sensitivity in vivo. Increased expression of PTP1B is associated with
insulin resistance in rodents and humans and deletion of PTP1B leads to
leanness and insulin sensitivity in rodents, suggesting that PTP1B may be a
very attractive molecular target for anti-obesity, anti-diabetic agents.
Original languageEnglish
Pages (from-to)2-7
Number of pages6
JournalActa Medica Saliniana
Volume38
Issue number1
Publication statusPublished - 1 Dec 2009

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Type 2 Diabetes Mellitus
Obesity
Rodentia
Anti-Obesity Agents
Developed Countries
Insulin Resistance
Adipose Tissue
Cardiovascular Diseases
Delivery of Health Care
Incidence
Neoplasms

Keywords

  • diabetes
  • obesity

Cite this

Protein Tyrosine Phosphatase 1B (PTP1B) in obesity and type 2 diabetes. / Delibegovic, Mirela; Mody, Nimesh.

In: Acta Medica Saliniana, Vol. 38, No. 1, 01.12.2009, p. 2-7.

Research output: Contribution to journalArticle

@article{5b10c3c77af14f808114c29061006518,
title = "Protein Tyrosine Phosphatase 1B (PTP1B) in obesity and type 2 diabetes",
abstract = "Increased incidence in obesity is reaching epidemic proportions and isplacing a major burden on the healthcare systems in developed countries.Obesity is a major risk factor for the development of type 2 diabetes, metabolicsyndrome, cardiovascular disease and cancer. Thus, the search formolecules that regulate the development of obesity and its associated pathologiesis ongoing. Protein tyrosine phosphatase 1B (PTP1B) has beenfound to be a major regulator of body fat stores, energy balance, and insulinsensitivity in vivo. Increased expression of PTP1B is associated withinsulin resistance in rodents and humans and deletion of PTP1B leads toleanness and insulin sensitivity in rodents, suggesting that PTP1B may be avery attractive molecular target for anti-obesity, anti-diabetic agents.",
keywords = "diabetes, obesity",
author = "Mirela Delibegovic and Nimesh Mody",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "38",
pages = "2--7",
journal = "Acta Medica Saliniana",
issn = "0350-364X",
publisher = "University Clinical Center Tuzla",
number = "1",

}

TY - JOUR

T1 - Protein Tyrosine Phosphatase 1B (PTP1B) in obesity and type 2 diabetes

AU - Delibegovic, Mirela

AU - Mody, Nimesh

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Increased incidence in obesity is reaching epidemic proportions and isplacing a major burden on the healthcare systems in developed countries.Obesity is a major risk factor for the development of type 2 diabetes, metabolicsyndrome, cardiovascular disease and cancer. Thus, the search formolecules that regulate the development of obesity and its associated pathologiesis ongoing. Protein tyrosine phosphatase 1B (PTP1B) has beenfound to be a major regulator of body fat stores, energy balance, and insulinsensitivity in vivo. Increased expression of PTP1B is associated withinsulin resistance in rodents and humans and deletion of PTP1B leads toleanness and insulin sensitivity in rodents, suggesting that PTP1B may be avery attractive molecular target for anti-obesity, anti-diabetic agents.

AB - Increased incidence in obesity is reaching epidemic proportions and isplacing a major burden on the healthcare systems in developed countries.Obesity is a major risk factor for the development of type 2 diabetes, metabolicsyndrome, cardiovascular disease and cancer. Thus, the search formolecules that regulate the development of obesity and its associated pathologiesis ongoing. Protein tyrosine phosphatase 1B (PTP1B) has beenfound to be a major regulator of body fat stores, energy balance, and insulinsensitivity in vivo. Increased expression of PTP1B is associated withinsulin resistance in rodents and humans and deletion of PTP1B leads toleanness and insulin sensitivity in rodents, suggesting that PTP1B may be avery attractive molecular target for anti-obesity, anti-diabetic agents.

KW - diabetes

KW - obesity

M3 - Article

VL - 38

SP - 2

EP - 7

JO - Acta Medica Saliniana

JF - Acta Medica Saliniana

SN - 0350-364X

IS - 1

ER -